105+ Pages Exclusive Report 2028 on Healthcare Cybersecurity Industry is added to the library of Xcellent Insights. Rising adoption of cloud-based solutions in the healthcare sector is a key factor expected to drive global market revenue growth during the forecast period
Pune, Jan. 25, 2023 (GLOBE NEWSWIRE) — The global Healthcare Cybersecurity Market Size is estimated to develop at a substantial CAGR for the duration of the prediction. Key factors such as increasing incidence of cyberattacks and data breaches in the healthcare sector, rapid adoption of mobile device applications and platforms, and rising awareness about the importance of healthcare cybersecurity are expected to fuel global market revenue growth during the forecast period.
Healthcare cybersecurity is one of the most essential components of the medical sector that involves protection of valuable insights, healthcare data, and patient’s personal information from external and internal cyberattacks. Hospitals, clinics, biotechnology, and pharmaceutical companies use various information storing systems such as HER systems, practice management systems, and e-prescribing software. However, large data is prone to data breaching and cyber-attacks. To cater to this problem, healthcare centers are seen to deploy advanced cybersecurity solutions and protect large databases. Moreover, many companies are focused on launching novel and innovative cybersecurity solutions for the healthcare sector.
Download Sample PDF Copy of Report (Including Full TOC, List of Tables & Figures, and Chart): https://www.xcellentinsights.com/enquiry/sample/99406
Factors such as increasing adoption of cybersecurity solutions across hospitals, clinics, and ambulatory care centers, improving healthcare infrastructure, rising healthcare spending, and rising investments in developing more enhanced and cost-effective healthcare cybersecurity systems are expected to boost global market growth between 2022 and 2028.
However, high cost of healthcare cybersecurity solutions, lack of suitable infrastructure and budget constraints to deploy advanced solutions, and dearth of trained professionals are some key factors expected to hamper overall market growth during the forecast period.
Healthcare Cybersecurity Industry Recent Developments:
In February 2020, GE Healthcare announced the launch of new medical device cybersecurity offering medical device expertise, process management tools and artificial intelligence to help healthcare organizations deal with cybersecurity threats.
In August 2022, Happiest Minds Technologies, a global IT solutions company announced the launch of cybersecurity services in the healthcare vertical.
Integrated Systems Segment To Register Steady Revenue CAGR:
The integrated systems segment is expected to register steady revenue CAGR over the forecast period owing to increasing cyber threats in the healthcare sector, growing awareness about cloud-based solutions and software, and high adoption of integrated systems to reduce cybersecurity risks and enhance safety.
Hospitals Segment to Account for Largest Revenue Share:
The hospitals segment is expected to account for largest revenue share between 2022 and 2028. This can be attributed to increasing number of cyber-attacks in hospitals, improving healthcare infrastructure, and rising adoption of cloud-based and advanced cybersecurity solutions in hospitals.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share during the forecast period. The growth of this market can be attributed to factors such as presence of well-established healthcare infrastructure and facilities, rapid adoption of advanced cybersecurity solutions in healthcare centers to cater to rising number of data breaching and cyberattacks, and presence of leading market players.
List of Key Players Operating in the Healthcare Cybersecurity Market:
Epic Systems Corporation
eClinicalWorks
Practice Fusion
NextGen Healthcare
Allscripts
Cerner
MEDITECH
General Electric Healthcare IT
Athenahealth
McKesson
AmazingCharts
E-MDs
Care360
Vitera
Browse complete Report Summary with TOC here: https://www.xcellentinsights.com/reports/healthcare-cybersecurity-market-99406
The global healthcare cybersecurity market has been segmented based on type, application, and region:
Healthcare Cybersecurity Market Segment by Type:
Stand-alone Systems
Integrated Systems
Healthcare Cybersecurity Market Segment by Application:
Hospitals
Clinics
Others
Healthcare Cybersecurity Market Segment by Region:
North America (USA, Canada)
Europe (Germany, France, UK, Italy, Russia)
Asia Pacific (China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam)
Latin America (Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, U.A.E)
Key Reasons to Purchase:
Estimates 2022 to 2028 healthcare cybersecurity market current market trends and development trends
Market dynamics along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the healthcare cybersecurity market
Competitive landscape involving market share of the major players, new strategies and projects adopted by players in the last five years
Comprehensive company profiles covering product offerings, key financial information, SWOT analysis and strategies employed by major market players
Brief about impact of COVID-19 on the global healthcare cybersecurity market
Key Questions Addressed in the Report:
What revenue CAGR is the global market expected to register during the forecast period?
Which key players are leading in the global healthcare cybersecurity market?
What is the expected market size of the global healthcare cybersecurity market between 2022 and 2028?
What factors are expected to open new growth avenues and opportunities for existing and emerging market players?
What are some of the key challenges that the global market is expected to face during the forecast period?
Which region is expected to account for largest revenue share over the forecast period?
You can Purchase the Complete Report here: https://www.xcellentinsights.com/checkout/99406
About Us:
Xcellent Insights is a one-stop solution for market research and consulting. Our portfolio of services includes syndicate and bespoke research reports driven by market intelligence studies that allow you to add value to your trading decisions. You can count on us for end-to-end market research, market intelligence and service research and services. Having a diverse portfolio across multiple industries, Market Reports excels in providing in-depth analysis and covering the latest market and industry trends.
Nio (NYSE: NIO), a stock that rode the electric vehicle (EV) hype in 2021, turned out to be among the biggest losers in 2022 — it plunged 69% last year. At current prices, Nio could be a rare opportunity to buy a growth stock in a fast-growing industry. Here are the three biggest reasons why Nio stock is a solid buy right now for 2023.
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has been a money machine for his shareholders since taking the reins in 1965. Through this past weekend, he's presided over a nearly 3,800,000% increase in the value of Berkshire's Class A shares (BRK.A).
High-yield dividend stocks can be sources of passive income no matter what the stock market is doing. Many high-yield savings accounts now offer interest rates of more than 4%, which creates a real opportunity cost for investing in stocks that simply didn't exist when interest rates were close to 0%. Devon Energy (NYSE: DVN), Mativ Holdings (NYSE: MATV), and Kinder Morgan (NYSE: KMI) are dividend stocks that not only have significantly higher yields than the risk-free rate, but have growing businesses that could drive share price appreciation, too.
Let's see if some analysis can provide the answer to whether or not investors should consider SoFi stock right now. Today, while student financing remains a major part of its business, it offers a broad array of services, such as personal banking, investing, credit cards, and mortgages.
(Bloomberg) — The selloff in Gautam Adani’s corporate empire accelerated on Friday, erasing more than $51 billion of market value in two sessions as Asia’s richest man struggles to contain the fallout from a scathing report by US short seller Hindenburg Research.Most Read from BloombergAdani Rout Crosses $51 Billion as Stocks Plunge by Daily LimitsWe Asked ChatGPT to Make a Market-Beating ETF. Here’s What HappenedHindenburg vs Adani: The Short Seller Taking On Asia’s Richest PersonPutin Plans N
Dow Jones futures fell slightly Friday after key inflation data. Intel stock plunged over 10% on an earnings miss.
A new era is about to begin at Toyota. The reasoning of the Japanese behemoth has always been that consumers were not ready to adopt electric vehicles. As a result, Toyota favored a policy of small steps.
These two high-yielders pay reliable and growing distributions, but another high-yield stock does not.
Five of the biggest U.S. chipmakers were set to erase nearly $15 billion in market value on Friday after Intel Corp stumped Wall Street with dismal earnings projections, fanning fears around a slump in the personal-computer market. The company predicted a surprise loss for the first quarter and its revenue forecast was $3 billion below estimates as it also struggled with slowing growth in the data center business. Intel shares fell 10% before the bell, with rival Advanced Micro Devices, Nvidia, Applied Materials and Qualcomm losing between 0.8% and 3.2%.
Enphase Energy (ENPH) closed the most recent trading day at $208.02, moving -1.09% from the previous trading session.
The average of price targets set by Wall Street analysts indicates a potential upside of 103.2% in Dynavax Technologies (DVAX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
While the overall stock market direction so far this year remains up, the path ahead still presents plenty of potential headwinds. Inflation has yet to be properly tamed, the geopolitical map remains uncertain with Russia’s invasion of Ukraine still ongoing and Covid variants could reappear at any time. Add in the prospect for a fiery battle in Congress around raising the debt ceiling, and Oppenheimer’s Chief Investment Strategist John Stoltzfus thinks market volatility is “unlikely to leave the
The Federal Reserve on Wednesday will hike rates by a quarter-point, a downshift from December but will make sure to sound hawkish, economists said.
The wireless business is AT&T's (NYSE: T) main source of revenue and profits, but the company's fiber business shouldn't be ignored. AT&T is in the process of building out its fiber network across the United States, an expensive proposition that has taken time to pay off. AT&T added 1.2 million fiber subscribers during 2022, boosting its total to 7.2 million.
Earnings season for the quarter that ended Dec. 31, 2022, is now underway, and Microsoft (NASDAQ: MSFT) was the first of the major technology companies to report. Microsoft's overall revenue growth slowed to a crawl, and its profits dipped compared to the same period in the prior year. Microsoft stock has declined by 28% from its all-time high, but here's why the $1.8 trillion megacap is a buy on the dip.
Berkshire Hathaway CEO Warren Buffett's incredible market-beating track record is the stuff of legend. In fact, if you held a $1,000 stake in Berkshire Hathaway on the day that Buffett purchased the company in May 1965, that position would now be worth well over $26 million. With that kind of performance, it's no surprise that many consider Buffett the single best investor in history.
Chevron reported disappointing fourth-quarter earnings, pushing shares down in premarket trading. Chevron (ticker: CVX) shares fell 0.9% to $186.12 early on Friday. Chevron delighted investors late on Wednesday after announcing an increase to its dividend, and a new plan to repurchase $75 billion worth of shares.
Famed investor Cathie Wood, chief executive of Ark Investment Management, keeps unloading what was the No. 1 holding in Ark's flagship fund. Ark funds sold 683,698 shares of Exact Sciences Jan. 25, valued at $43.9 million as of that day's close. Exact Sciences' stock has lost 7% over the past year, but it has jumped 113% since Oct. 14, buoyed by strong earnings and the overall market's rally.
Shareholders of Catalyst Pharmaceuticals (NASDAQ: CPRX) got a nasty shock on Jan. 23 when the company reported that a competitor, Teva Pharmaceutical Industries (NYSE: TEVA), was planning to make a generic version of its only marketed drug, Firdapse. With Catalyst's shares falling 30% in a day before slightly recovering, it's clear that the market is interpreting Teva's actions as severely threatening, and it's reasonable for investors to wonder if it's time to start looking for the door. First, let's take a moment to understand what Firdapse means for Catalyst Pharmaceuticals.
Industry experts predict the real estate sector will register slowed economic growth in 2023 amid higher-than-average inflation levels and growing recession fears. And real estate investment trusts (REITs) have historically remained well-positioned to weather economic uncertainties. Even though rental rates have been cooling over the past couple of months, they are significantly higher than in 2021. Strong rental pricing should allow properties to improve their balance sheets and liquidity to cu